This inventor holds 14 USPTO granted patents and 12 published patent applications, plus 4 CIPO patents and 11 EPO patents. Top assignees: Alzheon, Inc., National Oilwell Varco, L.p., Amca International Corporation. Active years: 1988-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Houston, TX (US) (1988)
- Eagan, MN (US) (1990)
- Spring, TX (US) (2016)
- Lexington, MA (US) (2019)
- Framingham, MA (US) (2020 - 2024)
Company Filing History:
9 out of 9 
3 out of 593 
2 out of 57 Years Active: 1988-2025
Title: John A Hey: Innovator in Neurodegenerative Disorder Treatments
Introduction
John A Hey is a prominent inventor based in Lexington, MA (US), known for his significant contributions to the field of neurodegenerative disorders. With a total of 14 patents to his name, he has made remarkable strides in developing treatments for conditions such as Alzheimer's disease.
Latest Patents
Among his latest patents, John A Hey has focused on sulfopropanoic acid derivatives for treating neurodegenerative disorders. His work includes the use of a compound of Formula (I) and the development of compositions and methods aimed at treating and preventing neurodegenerative diseases. These innovations are crucial in the ongoing battle against conditions like Alzheimer's disease.
Career Highlights
John A Hey is currently associated with Alzheon, Inc., where he continues to push the boundaries of research and development in the pharmaceutical industry. His dedication to finding effective treatments for neurodegenerative disorders has positioned him as a key figure in this vital area of healthcare.
Collaborations
Throughout his career, John has collaborated with notable professionals in the field, including Martin Tolar and Petr Kocis. These partnerships have enhanced his research efforts and contributed to the advancement of innovative solutions for neurodegenerative diseases.
Conclusion
In summary, John A Hey is a distinguished inventor whose work in neurodegenerative disorder treatments has the potential to change lives. His ongoing research and patent contributions reflect his commitment to improving healthcare outcomes for patients suffering from these challenging conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile